From: MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
Variable | Number | % |
---|---|---|
Age (years) | 42.58 ± 12.15a |  |
Diagnostic category | Â | Â |
 Normal | 541 | 46.4 |
 Low-grade CIN | 99 | 8.5 |
 High-grade CIN | 327 | 28.0 |
 Cancer | 200 | 17.1 |
FIGO stage | Â | Â |
 I | 138 | 69.0 |
 II | 53 | 26.5 |
 IV | 9 | 4.5 |
Tumor grade b | Â | Â |
 Well/Moderate | 117 | 65.7 |
 Poor | 61 | 34.3 |
Cell type | Â | Â |
 SCC | 164 | 82.0 |
 AC/ASC | 30 | 15.0 |
 Others | 6 | 3.0 |
Tumor size | Â | Â |
  ≤ 4 cm | 145 | 72.5 |
  > 4 cm | 55 | 27.5 |
Lymphovascular invasion c | Â | Â |
 Negative | 95 | 64.6 |
 Positive | 52 | 35.4 |
Lymph node metastasis d | Â | Â |
 Negative | 141 | 77.5 |
 Positive | 41 | 22.5 |
Chemoradiation response e | Â | Â |
 Good | 38 | 77.6 |
 Bad | 11 | 22.4 |
SCC antigen f | Â | Â |
 Negative | 100 | 66.7 |
 Positive | 50 | 33.3 |
HPV test in CIN g | Â | Â |
 Negative | 39 | 11.5 |
 Positive | 300 | 88.5 |